Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2411918Generated: November 3, 2026

(6-Bromopyridin-3-yl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone → 1-{5-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]pyridin-2-yl}-5-isopropylimidazolidine-2,4-dione

https://huagongshe.com/reaction/2411918

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(6-Bromopyridin-3-yl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanoneHCID 58484661—
Reactant1-{5-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]pyridin-2-yl}-5-isopropyl-3-(4-methoxybenzyl)imidazolidine-2,4-dioneHCID 71252561—
Reactant5-Isopropyl-3-(4-methoxybenzyl)imidazolidine-2,4-dioneHCID 71252864—
Product1-{5-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]pyridin-2-yl}-5-isopropylimidazolidine-2,4-dioneHCID 71252789—

Reaction Steps

Using (6-bromopyridin-3-yl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (225 mg) described in Preparation Example 127 and 5-isopropyl-3-(4-methoxybenzyl)imidazolidine-2,4-dione (157 mg) described in Preparation Example 209 and by the reaction and treatment in the same manner as in Example 508, the title compound (138 mg) was obtained via 1-{5-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]pyridin-2-yl}-5-isopropyl-3-(4-methoxybenzyl)imidazolidine-2,4-dione.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08816079B2
Source datasetuspto-grants-2014_08
ORD IDord-ccef61b98cd14568942da90d130cf603
Source noteuspto-grants-2014_08